Multidisciplinary analysis of the prognosis and biological function of NUBPL in gastric cancer
BackgroundResearchers are currently concentrating on molecular markers and potential therapeutic targets associated with gastric cancer in light of recent developments in precision medicine and molecular biology. Disulfidptosis was first proposed in 2023 as a novel programmed cell death mode associa...
Saved in:
| Main Authors: | Luqian Liu, Fengyu Zhang, Jiaye Yu, Pingping Dong, Jing Deng, Weiwei Liu, Xinlei Cao, Juanjuan Huang, Xiaoming Lin, Xiangyang Xue |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1603898/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of gastric cancer subtypes based on disulfidptosis-related genes: GPC3 as a novel biomarker for prognosis prediction
by: Nan Yi, et al.
Published: (2024-12-01) -
Identification of disulfidptosis-related subtypes in gastric cancer and GAMT is a key gene during disulfidptosis
by: Wenxue Wu, et al.
Published: (2025-01-01) -
Interplay of disulfidptosis and the tumor microenvironment across cancers: implications for prognosis and therapeutic responses
by: Shengshan Xu, et al.
Published: (2025-07-01) -
Tissue Biomarkers in Gastric Cancer Treatment: Present and Future
by: Giulia Airò, et al.
Published: (2024-11-01) -
Disulfidptosis: a novel gene-based signature predicts prognosis and immunotherapy efficacy of pancreatic adenocarcinoma
by: Jingyang Yin, et al.
Published: (2025-03-01)